New weight loss pill more ‘tolerable’ than jabs shown to be effective in key trial The tablet could be a cheaper and more convenient alternative to injections The Independent UK · Aug 7, 2025
High demand expected for new daily weight loss pill The tablet could be a cheaper and more convenient alternative to injections. Evening Standard · Aug 7, 2025
‘Shock’ as study reveals how weight-loss pill stacks up against injections Shares in a pharmaceutical company plummeted after the results were made public The Independent UK · Aug 7, 2025
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Thursday. Benzinga · Aug 7, 2025
Just three weekly servings of popular snack could raise diabetes risk by 20% IN FULL The Independent UK · Aug 7, 2025
Potatoes could raise your risk of type 2 diabetes. But how you prepare them matters, study finds Eating more potatoes was tied to a higher risk of type 2 diabetes risks in a study that spanned three decades – and French fries were the main culprit. Euronews · Aug 7, 2025
Hold the fries! How your favorite salty side can increase your risk of type 2 diabetes The study found eating three servings of fries a week could increase your risk of developing type 2 diabetes by 20 percent The Independent UK · Aug 6, 2025
Eating chips three times a week raises type 2 diabetes risk by 20%, study finds Baking, boiling or mashing potatoes raises risk by 5% and replacing with whole grains lowers risk significantly The Guardian - UK · Aug 6, 2025
Eating fries over boiled potatoes increases type 2 diabetes risk – study But wholegrain foods remained the best option to reduce risk, experts said. The Independent UK · Aug 6, 2025
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply Danish company to cut costs and consider layoffs after competition from Mounjaro and the copycat market The Guardian - UK · Aug 6, 2025
Bryan Johnson Spent Millions To Be 18 Again—Says Novo Nordisk's Ozempic Anti-Aging Hype Is Misleading: 'Data Is Not There' Tech entrepreneur Bryan Johnson, who spends $2 million annually on anti-aging treatments, refutes claims that Novo Nordisk AS‘s (NYSE:NVO) Ozempic demonstrates anti-aging properties. Johnson disputed a post on social platform X suggesting the diabetes drug reverses biological aging by 3.1 years. Benzinga · Aug 6, 2025
4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) are currently up over 20.6% after the company released positive results from its Spectra trial. Benzinga · Aug 1, 2025
Weight loss drug demand continues to grow in the UK – here’s what’s being done to keep supplies readily available Over a fifth of people in the UK have tried to access a weight loss drug in the last year, according to a recent poll. The Conversation · Jul 31, 2025
The Independent UK · Jul 30, 2025 The 3 diets that reduce the risk of type 2 diabetes Experts say the diets are effective, regardless of a person’s ethnicity
The Independent UK · Jul 30, 2025 Study shows which diets can stave off type 2 diabetes regardless of ethnicity The analysis included 826,000 people, with researchers from the University of Cambridge looking at 33 studies on three different diets.
The Independent UK · Jul 30, 2025 The truth about the ‘bad’ sugars in fruit – and how much children should have The ‘sugar-free’ movement has demonised sugar with claims it’s fattening and causes diabetes
BANG Premier · Jul 30, 2025 Lance Bass: 'It was a blessing to develop diabetes' Lance Bass says getting diabetes was “a blessing in disguise” as it has made him healthier.
The Conversation · Jul 30, 2025 Should I limit how much fruit my child eats because it contains sugar? Parents are often told fruit is “bad” because it contains sugar, prompting concerns about how much fruit they should allow their child to eat.
International Business Times · Jul 29, 2025 Novo Nordisk Cuts Earning Forecasts Again, Names New CEO Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, on Tuesday lowered its earning forecasts again as it unveiled a new chief executive to tackle "recent market challenges".
Benzinga · Jul 29, 2025 Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment Ozempic, experienced a significant downturn on Tuesday following the company’s decision to trim its 2025 financial outlook.
The Independent UK · Jul 26, 2025 Robert F. Kennedy Jr loves them. But do you really need a continuous glucose monitor? The devices have surged in popularity among people even without diabetes
The Independent UK · Jul 23, 2025 New research could change the way type 1 diabetes is diagnosed IN FULL
The Independent UK · Jul 23, 2025 New form of type 1 diabetes identified in study Clinicians in parts of Africa had long suspected that some children diagnosed with type 1 diabetes did not quite fit the standard profile
The Independent UK · Jul 21, 2025 Forever chemicals in household objects linked to type 2 diabetes, scientists warn PFAS can disrupt metabolism and increase diabetes risk, study finds